The OPTION Clinical Trial

The OPTION Clinical Trial
The purpose of the OPTION trial is to determine if left atrial appendage closure with the WATCHMAN FLXTM Implant is a reasonable alternative to blood thinners for stroke protection following AFib ablation.
By joining this study, you may have the opportunity to receive the WATCHMAN FLX Implant.* If you agree to be in this study, you will be expected to visit your study doctor for required screenings. You also may be required to attend follow-up visits about once a year for three years.